PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.750448
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34795668
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all